ARAY
Price
$0.93
Change
-$0.04 (-4.12%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
104.82M
76 days until earnings call
Intraday BUY SELL Signals
BWAY
Price
$15.13
Change
+$0.34 (+2.30%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
300.65M
111 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ARAY vs BWAY

Header iconARAY vs BWAY Comparison
Open Charts ARAY vs BWAYBanner chart's image
Accuray
Price$0.93
Change-$0.04 (-4.12%)
Volume$9.24K
Capitalization104.82M
BrainsWay
Price$15.13
Change+$0.34 (+2.30%)
Volume$730
Capitalization300.65M
ARAY vs BWAY Comparison Chart in %
ARAY
Daily Signal:
Gain/Loss:
BWAY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ARAY vs. BWAY commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAY is a Hold and BWAY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (ARAY: $0.97 vs. BWAY: $14.78)
Brand notoriety: ARAY and BWAY are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ARAY: 293% vs. BWAY: 59%
Market capitalization -- ARAY: $104.82M vs. BWAY: $300.65M
ARAY [@Medical/Nursing Services] is valued at $104.82M. BWAY’s [@Medical/Nursing Services] market capitalization is $300.65M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $219.36B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARAY’s FA Score shows that 0 FA rating(s) are green whileBWAY’s FA Score has 0 green FA rating(s).

  • ARAY’s FA Score: 0 green, 5 red.
  • BWAY’s FA Score: 0 green, 5 red.
According to our system of comparison, BWAY is a better buy in the long-term than ARAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARAY’s TA Score shows that 3 TA indicator(s) are bullish while BWAY’s TA Score has 4 bullish TA indicator(s).

  • ARAY’s TA Score: 3 bullish, 6 bearish.
  • BWAY’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BWAY is a better buy in the short-term than ARAY.

Price Growth

ARAY (@Medical/Nursing Services) experienced а -16.94% price change this week, while BWAY (@Medical/Nursing Services) price change was -2.64% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -4.89%. For the same industry, the average monthly price growth was -7.90%, and the average quarterly price growth was +10.70%.

Reported Earning Dates

ARAY is expected to report earnings on Feb 04, 2026.

BWAY is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Medical/Nursing Services (-4.89% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BWAY($301M) has a higher market cap than ARAY($105M). BWAY YTD gains are higher at: 60.392 vs. ARAY (-53.293). ARAY has higher annual earnings (EBITDA): 20.2M vs. BWAY (8.3M). BWAY has more cash in the bank: 78M vs. ARAY (57.4M). BWAY has less debt than ARAY: BWAY (6.13M) vs ARAY (176M). ARAY has higher revenues than BWAY: ARAY (459M) vs BWAY (46.1M).
ARAYBWAYARAY / BWAY
Capitalization105M301M35%
EBITDA20.2M8.3M243%
Gain YTD-53.29360.392-88%
P/E RatioN/A47.27-
Revenue459M46.1M996%
Total Cash57.4M78M74%
Total Debt176M6.13M2,871%
FUNDAMENTALS RATINGS
ARAY vs BWAY: Fundamental Ratings
ARAY
BWAY
OUTLOOK RATING
1..100
5377
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
72
Overvalued
PROFIT vs RISK RATING
1..100
10049
SMR RATING
1..100
8869
PRICE GROWTH RATING
1..100
9343
P/E GROWTH RATING
1..100
3496
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BWAY's Valuation (72) in the Medical Specialties industry is in the same range as ARAY (85). This means that BWAY’s stock grew similarly to ARAY’s over the last 12 months.

BWAY's Profit vs Risk Rating (49) in the Medical Specialties industry is somewhat better than the same rating for ARAY (100). This means that BWAY’s stock grew somewhat faster than ARAY’s over the last 12 months.

BWAY's SMR Rating (69) in the Medical Specialties industry is in the same range as ARAY (88). This means that BWAY’s stock grew similarly to ARAY’s over the last 12 months.

BWAY's Price Growth Rating (43) in the Medical Specialties industry is somewhat better than the same rating for ARAY (93). This means that BWAY’s stock grew somewhat faster than ARAY’s over the last 12 months.

ARAY's P/E Growth Rating (34) in the Medical Specialties industry is somewhat better than the same rating for BWAY (96). This means that ARAY’s stock grew somewhat faster than BWAY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARAYBWAY
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
N/A
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
ARAY
Daily Signal:
Gain/Loss:
BWAY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTSUY23.170.01
+0.04%
Mitsubishi Corp.
AFGVY2.29N/A
N/A
Agfa-Gavaert NV
YNVYF0.10N/A
N/A
Ynvisible Interactive Inc.
BCKIF15.23N/A
N/A
Babcock International Group Plc
KARNF5.20N/A
N/A
Kernel Holding SA

ARAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARAY has been loosely correlated with QDEL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ARAY jumps, then QDEL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARAY
1D Price
Change %
ARAY100%
-4.84%
QDEL - ARAY
46%
Loosely correlated
-1.32%
ILMN - ARAY
41%
Loosely correlated
-1.52%
A - ARAY
41%
Loosely correlated
+0.39%
ICUI - ARAY
40%
Loosely correlated
-1.15%
NVST - ARAY
39%
Loosely correlated
-0.94%
More

BWAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BWAY has been loosely correlated with STIM. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if BWAY jumps, then STIM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BWAY
1D Price
Change %
BWAY100%
+2.33%
STIM - BWAY
34%
Loosely correlated
+0.33%
ISRG - BWAY
31%
Poorly correlated
+3.27%
ARAY - BWAY
31%
Poorly correlated
-4.84%
OFIX - BWAY
29%
Poorly correlated
+0.53%
DCTH - BWAY
28%
Poorly correlated
-1.62%
More